Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_assertion type Assertion NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_head.
- NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_assertion description "[We have shown that preoperative plasma levels of transforming growth factor-beta(1) (TGF-beta(1)), interleukin 6 (IL)-6, and its receptor (IL-6sR) are associated with prostate cancer progression and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_provenance.
- NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_assertion evidence source_evidence_literature NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_provenance.
- NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_assertion SIO_000772 15041717 NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_provenance.
- NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_assertion wasDerivedFrom befree-20140225 NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_provenance.
- NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_assertion wasGeneratedBy ECO_0000203 NP323245.RAkteo4ftQxCqPiX3l_gHRgoGK-gOUVa3XN8UYBv3Pr64130_provenance.